Rabbit Anti-Orexin Prepro Polyclonal Antibody, Unconjugated from Abcam
Anti-Human C5a / C5a des-Arg (neo-epitode) Monoclonal Antibody, Unconjugated, Clone 2952 from Cell Sciences
Rabbit Anti-Human Ubiquitin-conjugating enzyme E2N Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Anti-Acetyl CoA Carboxylase Antibody, Unconjugated from Cell Signaling Technology
Biology Products:(Date:12/4/2009)...am (EEG) is widely used by physicians and scientis...gical disorders. However, it has remained largely ... exact view of what is happening inside the brain....ical Cybernetics in Tbingen, Germany, have now fou...ithin the brain to that measured with EEG. These f...
(Date:12/4/2009)...al model of heart cells, University of Iowa invest...zyme, calmodulin kinase II (CaM kinase), disrupts ...study, which also involved Columbia University, wa...putational Biology . , "Recently, researchers h...II as a critical regulator of the heart,s response...
(Date:12/3/2009)..., Dec. 3 BIO-key Interna...in wireless public safety and finger-based biometr...rity of its shareholders at a Special Shareholder ...y,s Law Enforcement Division to Interact911 Mobile... in favor and 1.2% were opposed. ,, (Logo: htt...
Breaking Biology News(10 mins):How to read brain activity? 2U-Iowa study helps advance heart-related research 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Union of American Physicians and Dentists 3A Court Appointee El Sabaawi Practicing Medicine Without a License 3F 52846 1Union of American Physicians and Dentists 3A Court Appointee El Sabaawi Practicing Medicine Without a License 3F 52846 2SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 1SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 2SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 3SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 4Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 1Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 2Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 3Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 4Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 5Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 6(Date:12/2/2009)..., Dec. 2 Peregrine Pharm...ompletion of patient enrollment in a dose confirma...ts with relapsed glioblastoma multiforme (GBM), th...geted monoclonal antibody linked to a radioisotope...GBM. Cotara specifically targets cells at the cen...
(Date:12/2/2009)...e Netherlands, December 2 Pepscan ...mpany focusing on protein mimicking,technology for...nced that it,has appointed Wim E.M. Mol, Ph.D. as ...ll be responsible for all of Pepscans corporate fu...irection of the company. He brings to,Pepscan more...
(Date:12/2/2009)...Dec. 2 S*BIO Pte Ltd today announc...itor, SB1518, at The American Society of Hematolog...s. ,, Data will be presented on the clinical re...1518 detailing its safety, tolerability and pharma...levels ranging from 100 to 600 mg. These doses wer...
(Date:12/2/2009)... 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. ...al biopharmaceutical company focused on endocrine .... Food and Drug Administration (FDA) has granted F...athway inhibitor compound, perifosine (KRX-0401), ...myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx") ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3